Transmission Dynamics of Carbapenemase Genes in Carbapenem-Resistant Enterobacter cloacae: Insights from Guangdong Hospitals (2022–2024)

Study Background and Research Question

The global rise of carbapenem-resistant Enterobacteriaceae (CRE) represents a major threat to clinical therapeutics and public health. Enterobacter cloacae, in particular, has emerged as a significant contributor to multidrug-resistant infections in hospital settings. The COVID-19 pandemic has further complicated the landscape, with increased antibiotic use and disrupted healthcare practices potentially accelerating resistance spread. However, detailed investigations into the specific carbapenemase-encoding genes (CEGs) and their transmission patterns in carbapenem-resistant Enterobacter cloacae (CREC) during this period have remained scarce. To address this knowledge gap, the reference study conducted a systematic survey across eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024.

Key Innovation from the Reference Study

The principal innovation of this research lies in its comprehensive epidemiological and molecular characterization of CEGs within CREC isolates during a period of intensified antibiotic pressure. Notably, the study provides critical data on the chromosomal and plasmid locations of CEGs, delineates their transmission efficiency through conjugation experiments, and directly correlates these genetic features with clinical and demographic variables. Importantly, it offers one of the first multi-institutional, post-pandemic insights into the mobility and prevalence of CEGs in a highly impacted region.

Methods and Experimental Design Insights

The researchers collected 54 non-duplicate CREC isolates from eight tertiary hospitals. Identification was performed using MALDI-TOF MS and confirmed via 16S rRNA gene sequencing. To interrogate genetic determinants of resistance, the team applied:

• Variable temperature sodium dodecyl sulfate (SDS) plasmid elimination to differentiate chromosomal from plasmid-borne genes.
• PCR screening for major carbapenemase genes (including blaNDM-1, blaIMP, and blaKPC-2).
• Broth microdilution to determine antimicrobial susceptibility profiles.
• Plasmid conjugation assays to assess horizontal gene transfer efficiency.
• ERIC-PCR and NTSYS software for genotyping and cluster analysis of strain relatedness.
• Investigation of mobile genetic elements using targeted PCR, with a focus on insertion sequences such as ISEcp1.

This robust pipeline enabled the authors to map the genetic landscape of resistance and evaluate the epidemiological context of gene dissemination.

Core Findings and Why They Matter

The study's findings underscore the complexity and urgency of antimicrobial resistance management in clinical settings:

• High prevalence of CEGs: 85.2% (46/54) of isolates harbored carbapenemase-encoding genes (reference study).
• blaNDM-1 dominance: Of the isolates, 33.3% (18/54) carried blaNDM-1 on both chromosomes and plasmids, while 46.3% (25/54) carried it exclusively on plasmids. Only 3.7% (2/54) harbored blaIMP alone on plasmids, and a single isolate (1.9%) had both blaNDM-1 and blaKPC-2 on plasmids.
• Efficient horizontal gene transfer: Conjugation experiments demonstrated a 95.7% success rate for CEG transfer, with particularly high mobility for blaNDM-1 (95.5%) and blaIMP (100%), indicating a substantial risk for rapid hospital-wide dissemination.
• Multidrug resistance: CEG-positive isolates showed significantly higher resistance rates to key antimicrobials, including imipenem, cefepime, gentamicin, and fluoroquinolones, highlighting the clinical challenge of treating such infections.
• Mobile genetic elements: Six types were identified, with ISEcp1 being the most prevalent (87.0%). Isolates frequently contained multiple mobile elements, facilitating gene mobilization and diversity.
• Genotype diversity and epidemiology: Seventeen ERIC-PCR genotypes were found, with type E and G most common, spanning multiple hospitals and clinical departments. Notably, higher detection rates were observed in male and elderly patients, respiratory medicine, and sputum samples, providing actionable epidemiological insights.

These results emphasize the role of plasmid-borne CEGs, particularly blaNDM-1 (or, by IUPAC name, 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide resistance determinants), in driving multidrug resistance and their potential for rapid spread in hospital environments.

Comparison with Existing Internal Articles

Several internal resources complement the reference study by providing technical and workflow-oriented perspectives on resistance gene analysis and antibiotic selection:

• The article "Harnessing Protein Synthesis Inhibition: Strategic Applications" explores the foundational mechanisms of Chloramphenicol and its role as an antibiotic for molecular biology research, particularly in the context of plasmid selection and resistance monitoring.
• "Chloramphenicol in Plasmid Selection: Optimized Protocols & Solutions" details optimized workflows for using chloramphenicol in plasmid selection assays, including troubleshooting and protocol adaptation based on resistance gene transmission dynamics—directly relevant to the challenges highlighted by the Guangdong study.
• "Transmission Dynamics of Carbapenemase Genes in CREC During COVID-19" provides a focused summary of the same reference study, underscoring the dominance of plasmid-mediated blaNDM-1 and the clinical implications of efficient gene transfer.

Together, these articles bridge practical laboratory protocols with the broader public health challenge of resistance surveillance, reinforcing the need for high-fidelity selection agents and molecular tools in resistance research.

Protocol Parameters

• Plasmid selection assay: For stringent plasmids, use chloramphenicol at approximately 25 μg/ml; for relaxed plasmids, 170 μg/ml is recommended (product information).
• Antibiotic sensitivity testing: Employ standard broth microdilution methods, aligning with the reference study's methodology for reproducibility.
• Plasmid elimination protocol: Consider variable temperature SDS treatment to distinguish plasmid-encoded from chromosomal resistance determinants, as demonstrated in the reference study.
• Genotyping: ERIC-PCR combined with cluster analysis supports tracking of high-risk clones and epidemiological mapping.

Limitations and Transferability

While the study offers robust insights, several limitations should be considered:

• Geographical focus: The findings are specific to eight hospitals in Guangdong Province; transmission dynamics may differ in other regions or healthcare settings.
• Sample size: The analysis is based on 54 isolates, which, while informative, may not capture the full genetic diversity of CREC in wider populations.
• Temporal scope: The study covers a specific period during and immediately after the COVID-19 pandemic; ongoing surveillance is needed to assess longer-term trends.
• Genetic mechanisms: While multiple mobile genetic elements were identified, the exact mechanisms of CEG mobilization and integration merit further molecular dissection.

Despite these constraints, the protocols and analytical frameworks are transferable to other molecular epidemiology settings, particularly for laboratories seeking to monitor or mitigate the spread of plasmid-mediated resistance.

Research Support Resources

For researchers aiming to replicate or extend these workflows, Chloramphenicol (SKU A2512) is widely used as a bacterial protein synthesis inhibitor and as an antibiotic selection agent in plasmid-based assays. Its proven specificity for the bacterial 50S ribosomal subunit and well-characterized performance in molecular biology settings make it suitable for stringent plasmid selection and resistance gene analysis, as outlined in both the reference study and related internal articles. APExBIO supplies this reagent with high purity and validated protocols to support rigorous molecular genetics research.